ARQT
Price
$14.37
Change
+$0.86 (+6.37%)
Updated
Jun 6 closing price
Capitalization
1.61B
65 days until earnings call
IDYA
Price
$21.73
Change
+$0.63 (+2.99%)
Updated
Jun 6 closing price
Capitalization
1.85B
64 days until earnings call
Interact to see
Advertisement

ARQT vs IDYA

Header iconARQT vs IDYA Comparison
Open Charts ARQT vs IDYABanner chart's image
Arcutis Biotherapeutics
Price$14.37
Change+$0.86 (+6.37%)
Volume$2.44M
Capitalization1.61B
IDEAYA Biosciences
Price$21.73
Change+$0.63 (+2.99%)
Volume$789.21K
Capitalization1.85B
ARQT vs IDYA Comparison Chart
Loading...
ARQT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARQT vs. IDYA commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARQT is a Buy and IDYA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ARQT: $13.58 vs. IDYA: $19.56)
Brand notoriety: ARQT and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARQT: 60% vs. IDYA: 75%
Market capitalization -- ARQT: $1.61B vs. IDYA: $1.85B
ARQT [@Biotechnology] is valued at $1.61B. IDYA’s [@Biotechnology] market capitalization is $1.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARQT’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • ARQT’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, ARQT is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARQT’s TA Score shows that 1 TA indicator(s) are bullish while IDYA’s TA Score has 6 bullish TA indicator(s).

  • ARQT’s TA Score: 1 bullish, 6 bearish.
  • IDYA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than ARQT.

Price Growth

ARQT (@Biotechnology) experienced а -1.31% price change this week, while IDYA (@Biotechnology) price change was +2.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ARQT is expected to report earnings on Aug 13, 2025.

IDYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.85B) has a higher market cap than ARQT($1.61B). ARQT YTD gains are higher at: -2.513 vs. IDYA (-23.891). ARQT has higher annual earnings (EBITDA): -109.63M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. ARQT (228M). IDYA has less debt than ARQT: IDYA (19.2M) vs ARQT (111M). ARQT has higher revenues than IDYA: ARQT (197M) vs IDYA (7M).
ARQTIDYAARQT / IDYA
Capitalization1.61B1.85B87%
EBITDA-109.63M-323.14M34%
Gain YTD-2.513-23.89111%
P/E RatioN/AN/A-
Revenue197M7M2,814%
Total Cash228M676M34%
Total Debt111M19.2M578%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARQTIDYA
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
85%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
77%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 12 days ago
76%
Declines
ODDS (%)
Bearish Trend 18 days ago
89%
Bearish Trend 18 days ago
77%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ARQT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ARQT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with NRIX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARQT
1D Price
Change %
ARQT100%
-3.96%
NRIX - ARQT
47%
Loosely correlated
+2.76%
KRYS - ARQT
46%
Loosely correlated
-2.44%
IDYA - ARQT
44%
Loosely correlated
+0.72%
ROIV - ARQT
44%
Loosely correlated
-1.30%
BEAM - ARQT
43%
Loosely correlated
-0.88%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.72%
IMNM - IDYA
59%
Loosely correlated
+0.35%
CGON - IDYA
58%
Loosely correlated
-0.94%
NTLA - IDYA
57%
Loosely correlated
+3.59%
DNLI - IDYA
56%
Loosely correlated
-1.29%
CRNX - IDYA
56%
Loosely correlated
+1.39%
More